Integrating IoT & Emerging Technology to Optimise Trials and Patient Outcomes
EVENT HAS NOW PASSED
With 82% of clinical trial experts integrating IoT into their decentralised trials, it is critical for clinical trial, technology, and patient centricity leaders to identify and implement strategies which focus on patient-centred outcomes.
Emerging technology and IoT integrated within decentralised trials can enable data quality, accuracy, and accessibility whilst optimising R&D operations.
However, designing a trial that considers the needs of all stakeholders can be a lengthy process, resulting in high costs and added complexity, accelerating the need for an effective IoT and technology roadmap.
By attending this Summit, you will hear how the European pharma industry is currently leveraging IoT to streamline clinical R&D, enhance patient closeness, and optimise trial effectiveness.
Learn From Our Clinical Trials and Technology Experts
Bert Hartog, Research and Development Operations, Senior Director, The Janssen Pharmaceutical Companies of Johnson & Johnson
Terttu Haring, Global Head for Clinical Digital Innovation, Sanofi
Luis Garcia-Gancedo, Director, Digital Biomarkers, GSK
Nick Carroll, Executive Director Digital Health Transformation, R&D, AstraZeneca
Amy Apostoleris, Global Head of Digital Clinical Trials Solutions (DCTS), Medocity
Vanessa Gertsen, Vice President, Study Operations DCT, Care Access
Cristina De Juan, Global Clinical Sciences and Operations Innovation Lead, UCB
Damien Eggenspieler, Healthcare program director, SYSNAV Healthcare
Jonathan Bruno, Senior Project Manager, Digital Medicine and Translational Imaging, Pfizer
Karl-Ludwig Radek, EMEA Strategic Account Lead, Global Clinical Operations, The Janssen Pharmaceutical Companies of Johnson & Johnson
Joss Langford, Chief Technical Officer, Activinsights
Richard Dearden, Head of AI Digital Health, AstraZeneca
Lisa Shafe, Clinical Programme Leader, Roche
Paul deRoulhac, Digital Transformation Lead, Genentech
Steve Yates, Head of Marketing: EMEA, Egnyte
This event will provide you with the necessary tools to:
- Ensure you identify and select the right approach for your patients and company, to improve individual healthcare outcomes and enhance patient experience
- Simplify the IoT eco-system to avoid overbuilding systems and make clinical trials technology more effective to patient groups and end users
- Outline the regulatory pathway of GDPR to optimise data management compliance and ensure secure processing of patient data
- Leverage cross-functional industry collaboration to respond to clinical challenges, advance technology strategy, and enhance future clinical trial design
- Encourage lasting adoption and evolvement of emerging technology to optimise your R&D and advance clinical trials workforce
IoT Clinical Trials Europe - Agenda
Wednesday 19 January 2022
09:50 – 09:55 CET Opening Remarks from AMG World
09:55- 10:25 Need to Know vs Nice to Know: Defining IoT Use Cases to Allow for Successful User Outcomes
Presenter:
Bert Hartog, Research and Development Operations, Senior Director, The Janssen Pharmaceutical
Companies of Johnson & Johnson
10:30 – 11:00 Getting Closer to the World of the Patient with IoT Thinking
Presenter:
Joss Langford, Chief Technical Officer, Activinsights
11:05 – 11:35 Reinventing Mobility Assessment: How Digital Endpoints improve understanding of patient progress.
Presenter:
Damien Eggenspieler, Healthcare program director, SYSNAV Healthcare
11:40 – 12:00 Technology Demonstrations
12:00 – 12:30 Networking Lunch and Virtual Exhibition
12:30 – 13:30 Hybrid vs Remote Clinical Trials: Which Approach will Ease Patient Burden
Moderator: Steve Yates, Head of Marketing: EMEA, Egnyte
Panellists:
Terttu Haring, Global Head for Clinical Digital Innovation, Sanofi
Nick Carroll, Executive Director Digital Health Transformation, R&D, AstraZeneca
Karl Ludwig-Radek, EMEA Strategic Account Lead, Global Clinical Innovations, The Janssen Pharmaceutical Companies of Johnson & Johnson
Vanessa Gertsen, Vice President, Study Operations, Decentralised Clinical Trials, Care Access
13:35 – 14:05 Wearables: The Advancement of Digital End Points for Clinical Trial Data
Presenter:
Luis Garcia-Gancedo, Director, Digital Biomarkers, GSK
14:10 – 14:40 Evaluating the Impact of Electronic Data Strategy on Decentralised Clinical Trials
14:40 – 15:00 Networking Break and Virtual Exhibition
15:00-16:00 Utilising technology to incorporate the patient voice in clinical trials: Where Do We Go Next?
Moderator: Amy Apostoleris, Global Head of Digital Clinical Trials Solutions (DCTS), Medocity
Panellists:
Cristina De Juan, Global Clinical Sciences and Operations Innovation Lead, UCB
Lisa Shafe, Clinical Programme Lead, Roche
Richard Dearden, Head of AI Digital Health, AstraZeneca
Paul deRoulhac, Digital Transformation Lead, Genentech
16:00 Close of the conference
Who Should Attend:
IoT Clinical Trials Europe 2022 is designed for VP’s, Directors, Heads and Managers from:
- Clinical Operations / Intelligence
- Clinical Innovation / Development / R&D / Technology
- Digital Health / Medicine / Biomarkers
- Digital Transformation / Innovation / Operations / Strategy
- Decentralised Clinical Trials / Hybrid trials / Remote trials
- Data Management/ Analytics
- Patient Advocacy / Recruitment / Experience
- Patient Centred Outcomes
- Clinical Affairs / Regulatory Affairs / Medical Affairs
Our sponsors include technology, service & solution providers specializing in:
- Wearables/ Biosensors
- IoT Hardware, Software, Platforms, Infrastructure
- Data & Analytics
- Artificial Intelligence (AI) / Machine Learning (ML)
- ePro solutions
- e-Source
- eCOA
- e-Consent
- Cloud Computing
2022 Sponsors:
Sponsorship Opportunities:
Recent disruption has continued to re-shape the conventional approach to networking, creating an opportunity to continue business within a virtual setting.
Our attendees are actively working through their operational and transformational challenges, but they also require support from dedicated solution providers who can offer guidance, expertise and technology to help solve unique business problems.
It is critical that the vendor community continues to support their customers through open discussions and information exchange; as well as nurture existing relationships and building a pipeline of new and valuable leads.
For more information on how we are uniquely placed to help you shape and deliver your message to your target audience, contact us now!
Simon Wright
Commercial Director
Simon.wright@amg-world.co.uk